BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30420101)

  • 1. miR-218 inhibits gastric tumorigenesis through regulating Bmi-1/Akt signaling pathway.
    Wu Y; Tian S; Chen Y; Ji M; Qu Y; Hou P
    Pathol Res Pract; 2019 Feb; 215(2):243-250. PubMed ID: 30420101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways.
    Yuan KT; Li BX; Yuan YJ; Tan M; Tan JF; Dai WG; Feng WD; Zuo JD
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806499. PubMed ID: 30355273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
    Liu L; Tian YC; Mao G; Zhang YG; Han L
    Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
    Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P
    Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
    Xu M; Qin S; Cao F; Ding S; Li M
    Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-218 Inhibits Proliferation, Migration, and EMT of Gastric Cancer Cells by Targeting WASF3.
    Wang G; Fu Y; Liu G; Ye Y; Zhang X
    Oncol Res; 2017 Mar; 25(3):355-364. PubMed ID: 27642088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2.
    Yu L; Chen J; Liu Y; Zhang Z; Duan S
    Cancer Biomark; 2017 Dec; 21(1):105-116. PubMed ID: 29060929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer.
    Jiang K; Xie LF; Xiao TZ; Qiu MY; Wang WL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8861-8869. PubMed ID: 31696473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
    Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
    J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1.
    Xu L; Sun HB; Xu ZN; Han XL; Yin YY; Zheng Y; Zhao Y; Wang ZX
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7978-7988. PubMed ID: 31599423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-107 inhibits gastric cancer cell proliferation and metastasis by targeting PI3K/AKT pathway.
    Cheng F; Yang Z; Huang F; Yin L; Yan G; Gong G
    Microb Pathog; 2018 Aug; 121():110-114. PubMed ID: 29715534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
    Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
    Zeng B; Shi W; Tan G
    BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene.
    Jian B; Li Z; Xiao D; He G; Bai L; Yang Q
    Tumour Biol; 2016 Jul; 37(7):8941-9. PubMed ID: 26753960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-498 inhibits the proliferation, migration and invasion of gastric cancer through targeting BMI-1 and suppressing AKT pathway.
    You D; Wang D; Liu P; Chu Y; Zhang X; Ding X; Li X; Mao T; Jing X; Tian Z; Pan Y
    Hum Cell; 2020 Apr; 33(2):366-376. PubMed ID: 32056164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRP4 promotes migration and invasion of gastric cancer under the regulation of microRNA-140-5p.
    Mao Z; Wang Z; Zhang S; Pu Y; Wang J; Zhang T; Long Y; Liu Y; Ma Y; Zhu J
    Cancer Biomark; 2020; 29(2):245-253. PubMed ID: 32675391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.